ADA and severe combined immunodeficiency: In addition, there is a report of delayed onset T-cell leukaemia in a child treated for adenosine deaminase severe combined immunodeficiency (ADA-SCID) using Strimvelis®, the first γRV-gene therapy licensed in Europe [21].